BioXcel Therapeutics (BTAI) Profit Margin (2022 - 2026)
BioXcel Therapeutics (BTAI) profit margin from Sep 30, 2022 to Mar 31, 2026. The current BioXcel Therapeutics (BTAI) profit margin is -6042.86%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of BioXcel Therapeutics (BTAI)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | -10921.88% | +315.98% |
| 2024 | -2625.55% | -79.76% |
| 2023 | -12974.64% | -70.26% |
| 2022 | -43621.05% | N/A |
Comparison BioXcel Therapeutics (BTAI) profit margin with competitors
BioXcel Therapeutics (BTAI) profit margin is -6042.86%.